243 related articles for article (PubMed ID: 1532331)
1. Double role for pyruvate kinase type M2 in the expansion of phosphometabolite pools found in tumor cells.
Eigenbrodt E; Reinacher M; Scheefers-Borchel U; Scheefers H; Friis R
Crit Rev Oncog; 1992; 3(1-2):91-115. PubMed ID: 1532331
[TBL] [Abstract][Full Text] [Related]
2. Pyruvate kinase type M2: a crossroad in the tumor metabolome.
Mazurek S; Grimm H; Boschek CB; Vaupel P; Eigenbrodt E
Br J Nutr; 2002 Jan; 87 Suppl 1():S23-9. PubMed ID: 11895152
[TBL] [Abstract][Full Text] [Related]
3. Marker for renal cell carcinoma (RCC): the dimeric form of pyruvate kinase type M2 (Tu M2-PK).
Wechsel HW; Petri E; Bichler KH; Feil G
Anticancer Res; 1999; 19(4A):2583-90. PubMed ID: 10470199
[TBL] [Abstract][Full Text] [Related]
4. Pyruvate kinase type M2: a key regulator of the metabolic budget system in tumor cells.
Mazurek S
Int J Biochem Cell Biol; 2011 Jul; 43(7):969-80. PubMed ID: 20156581
[TBL] [Abstract][Full Text] [Related]
5. The tumor metabolome.
Mazurek S; Eigenbrodt E
Anticancer Res; 2003; 23(2A):1149-54. PubMed ID: 12820363
[TBL] [Abstract][Full Text] [Related]
6. Metabolic cooperation between different oncogenes during cell transformation: interaction between activated ras and HPV-16 E7.
Mazurek S; Zwerschke W; Jansen-Dürr P; Eigenbrodt E
Oncogene; 2001 Oct; 20(47):6891-8. PubMed ID: 11687968
[TBL] [Abstract][Full Text] [Related]
7. Effects of the human papilloma virus HPV-16 E7 oncoprotein on glycolysis and glutaminolysis: role of pyruvate kinase type M2 and the glycolytic-enzyme complex.
Mazurek S; Zwerschke W; Jansen-Dürr P; Eigenbrodt E
Biochem J; 2001 May; 356(Pt 1):247-56. PubMed ID: 11336658
[TBL] [Abstract][Full Text] [Related]
8. Studies on associations of glycolytic and glutaminolytic enzymes in MCF-7 cells: role of P36.
Mazurek S; Hugo F; Failing K; Eigenbrodt E
J Cell Physiol; 1996 May; 167(2):238-50. PubMed ID: 8613464
[TBL] [Abstract][Full Text] [Related]
9. The role of phosphometabolites in cell proliferation, energy metabolism, and tumor therapy.
Mazurek S; Boschek CB; Eigenbrodt E
J Bioenerg Biomembr; 1997 Aug; 29(4):315-30. PubMed ID: 9387092
[TBL] [Abstract][Full Text] [Related]
10. Pyruvate kinase isoenzyme M2 is a glycolytic sensor differentially regulating cell proliferation, cell size and apoptotic cell death dependent on glucose supply.
Spoden GA; Rostek U; Lechner S; Mitterberger M; Mazurek S; Zwerschke W
Exp Cell Res; 2009 Oct; 315(16):2765-74. PubMed ID: 19563799
[TBL] [Abstract][Full Text] [Related]
11. Regulation by glucagon of hepatic pyruvate kinase, 6-phosphofructo 1-kinase, and fructose-1,6-bisphosphatase.
Pilkis SJ; El-Maghrabi MR; McGrane M; Pilkis J; Claus TH
Fed Proc; 1982 Aug; 41(10):2623-8. PubMed ID: 6286362
[TBL] [Abstract][Full Text] [Related]
12. Tumor-specific pyruvate kinase isoenzyme M2 involved in biochemical strategy of energy generation in neoplastic cells.
Gumińska M; Ignacak J; Kedryna T; Stachurska MB
Acta Biochim Pol; 1997; 44(4):711-24. PubMed ID: 9584851
[TBL] [Abstract][Full Text] [Related]
13. Alterations in the activity and isozymic profile of human phosphofructokinase during malignant transformation in vivo and in vitro: transformation- and progression-linked discriminants of malignancy.
Vora S; Halper JP; Knowles DM
Cancer Res; 1985 Jul; 45(7):2993-3001. PubMed ID: 3159473
[TBL] [Abstract][Full Text] [Related]
14. Quantification of tumor type M2 pyruvate kinase (Tu M2-PK) in human carcinomas.
Eigenbrodt E; Basenau D; Holthusen S; Mazurek S; Fischer G
Anticancer Res; 1997; 17(4B):3153-6. PubMed ID: 9329624
[TBL] [Abstract][Full Text] [Related]
15. Glucose metabolism and angiogenesis in granulosa cell tumors of the ovary: activation of Akt, expression of M2PK, TKTL1 and VEGF.
Schmidt M; Kammerer U; Segerer S; Cramer A; Kohrenhagen N; Dietl J; Voelker HU
Eur J Obstet Gynecol Reprod Biol; 2008 Jul; 139(1):72-8. PubMed ID: 18394773
[TBL] [Abstract][Full Text] [Related]
16. Structural and kinetic differences between the M2 type pyruvate kinases from lung and various tumors.
Eigenbrodt E; Leib S; Krămer W; Friis RR; Schoner W
Biomed Biochim Acta; 1983; 42(11-12):S278-82. PubMed ID: 6326772
[TBL] [Abstract][Full Text] [Related]
17. Regulation of pyruvate kinase type M2 by A-Raf: a possible glycolytic stop or go mechanism.
Mazurek S; Drexler HC; Troppmair J; Eigenbrodt E; Rapp UR
Anticancer Res; 2007; 27(6B):3963-71. PubMed ID: 18225557
[TBL] [Abstract][Full Text] [Related]
18. The metabolic marker tumour pyruvate kinase type M2 (tumour M2-PK) shows increased expression along the metaplasia-dysplasia-adenocarcinoma sequence in Barrett's oesophagus.
Koss K; Harrison RF; Gregory J; Darnton SJ; Anderson MR; Jankowski JA
J Clin Pathol; 2004 Nov; 57(11):1156-9. PubMed ID: 15509675
[TBL] [Abstract][Full Text] [Related]
19. Tumour M2-pyruvate kinase: a gastrointestinal cancer marker.
Kumar Y; Tapuria N; Kirmani N; Davidson BR
Eur J Gastroenterol Hepatol; 2007 Mar; 19(3):265-76. PubMed ID: 17301655
[TBL] [Abstract][Full Text] [Related]
20. Quantitative detection of tumor M2-PK in serum and plasma.
Hugo F; Fischer G; Eigenbrodt E
Anticancer Res; 1999; 19(4A):2753-7. PubMed ID: 10470235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]